Alissa Visram, MD

Dr. Visram earned her MD at the University of Toronto (2014). She completed her internal medicine training at the University of Ottawa (2017), followed by hematology training at Dalhousie University (2019). She further completed fellowship training at the Mayo Clinic, including an advanced hematology clinical fellowship (2020), followed by a research fellowship, focused on understanding the epidemiology of precursor plasma cell disorders (2021). She also completed a Master of Public Health and Clinical Epidemiology at Harvard University (2022). Dr. Visram has been working as a staff physician in the Division of Hematology at the Ottawa Hospital and Assistant Professor in the Department of Medicine, University of Ottawa since 2021.
Dr. Visram’s research focus is in clinical trials in myeloma and cellular therapies, along with translational research in natural killer cell immunology for treating multiple myeloma. Dr. Visram was the recipient of the competitive International Myeloma Foundation Young Investigator Award in both 2021 and 2022.